GlyNAC (Glycine + NAC), graded Emerging-evidence on Magellan — small human trials show GlyNAC restores glutathione and improves oxidative-stress, mitochondrial and physical-function markers, but nearly all come from one research group, the largest placebo-controlled trial enrolled 24 older adults for 16 weeks, and benefits faded after stopping.
Source: The Journals of Gerontology: Series A 2022, PMID 35975308 ↗ · Nutraceuticals & Cellular Energizers · How Magellan grades evidence · Study write-up · evidence confidence: medium
GlyNAC is a nutritional supplement combining two amino acids, glycine and N-acetylcysteine (NAC, a precursor of cysteine), that together supply the building blocks the body needs to synthesize glutathione, its most abundant intracellular antioxidant. Glutathione levels and synthesis decline with age, and this deficiency has been linked to elevated oxidative stress and mitochondrial dysfunction, two proposed drivers of aging. By providing both precursor amino acids, GlyNAC is intended to restore glutathione production and, through it, counter oxidative stress and support mitochondrial function. Most of the human research on GlyNAC has been conducted by a single group at Baylor College of Medicine.
In small clinical trials, mostly pilot and open-label studies plus one randomized placebo-controlled trial of 24 older adults from the same laboratory, GlyNAC supplementation corrected glutathione deficiency and improved markers of oxidative stress, mitochondrial function, inflammation, insulin resistance, muscle strength, gait speed and cognition, and in mice it extended lifespan by about 24%. However, the human evidence base is limited by small samples, short duration and reliance on one research group, and an independent randomized dose-ranging trial in 114 healthy older adults found glutathione and oxidative-damage benefits mainly in participants with elevated baseline oxidative stress, so effects may be context-dependent; measured benefits also reversed after supplementation stopped. This evidence describes the glycine/NAC/glutathione mechanism and the GlyNAC combination studied in research settings, not this specific commercial product.
Peer-reviewed studies on the active compound — citations link to PubMed.
“GlyNAC supplementation improved glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, physical function and multiple hallmarks of aging in older adults.”
“GlyNAC supplementation increased length of life in mice by 24% while correcting glutathione deficiency and multiple defects of aging.”
“GlyNAC supplementation in older adults improved glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, and multiple hallmarks of aging.”
“GlyNAC corrected glutathione deficiency, oxidative stress and mitochondrial dysfunction”
“Dietary supplementation with the glutathione precursors cysteine and glycine fully restores glutathione synthesis and concentrations and lowers levels of oxidative stress and oxidant damages.”
“GlyNAC supplementation significantly improved fasted MFO by 30% (< 0.001), lowered MGO by 47% (< 0.01), decreased IR by 22% (< 0.01) and lowered FFA by 25% (< 0.01).”
Research describes the active mechanism and is not a claim about this specific product.
Across large randomized trials and meta-analyses, marine omega-3s reliably reduce serum…
Across meta-analyses and randomized trials, creatine monohydrate combined with…
In humans, randomized trials and meta-analyses most consistently show that astaxanthin…
Multiple meta-analyses of randomized trials indicate that oral zinc, started soon after…
Yes — its active compound is linked to 16 peer-reviewed studies, summarized and cited above.
You can buy it on Amazon via the link above; Magellan earns a small affiliate commission at no extra cost to you, which does not affect the evidence grade.
Dietary supplements and devices are generally well tolerated but are not a substitute for medical care. Talk to your physician before starting, especially if you take medication or have a health condition.